Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00000310 · ClinicalTrials.gov registry record · Phase 2
Serotonin/Dopamine Antagonism of Cocaine Effect: 2 - 2
A Phase 2 study, sponsored by National Institute on Drug Abuse (NIDA).
- Terminated
- Registry status
- Phase 2
- Development phase
NCT00000310 is a Phase 2 study that was terminated before completion, run by National Institute on Drug Abuse (NIDA).
The verdict
NCT00000310, a Phase 2 study, was terminated before completion, sponsored by National Institute on Drug Abuse (NIDA).
- TERMINATED
- Registry status
- Phase 2
- Development phase
Study Summary
The purpose of this study is to evaluate use of risperidone with cocaine abusers. Study measures incorporate an appropriate integration of behavioral and neurobiological indices.
Interventions
- DRUG Risperidone
Trial Details
| Field | Value |
|---|---|
| Start Date | 1996-01 |
| Est. Completion | 1996-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00000310
The ClinicalTrials.gov registry entry for NCT00000310 describes a study currently listed as terminated, categorized as Phase 2. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is National Institute on Drug Abuse (NIDA), which has 335 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Risperidone is the first listed.
NCT00000310 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00000310 about?
NCT00000310 is a clinical study titled "Serotonin/Dopamine Antagonism of Cocaine Effect: 2 - 2". The purpose of this study is to evaluate use of risperidone with cocaine abusers. Study measures incorporate an appropriate integration of behavioral and neurobiological indices.
What is the current status of trial NCT00000310?
This trial is currently terminated. It is a Phase 2 study. The study started on 1996-01. Estimated completion is 1996-03.
What interventions are being tested in trial NCT00000310?
The interventions under investigation include: Risperidone (DRUG).
Who is sponsoring clinical trial NCT00000310?
This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.